SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-050007
Filing Date
2023-10-27
Accepted
2023-10-27 17:27:49
Documents
14
Period of Report
2023-10-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20009756x7_8k.htm   iXBRL 8-K 33852
2 EXHIBIT 99.1 ny20009756x7_ex99-1.htm EX-99.1 9084
6 ny20009756x7_ex99-1img01.jpg GRAPHIC 5708
  Complete submission text file 0001140361-23-050007.txt   192830

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20231026.xsd EX-101.SCH 3907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20231026_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20231026_pre.xml EX-101.PRE 16072
8 EXTRACTED XBRL INSTANCE DOCUMENT ny20009756x7_8k_htm.xml XML 4208
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 231356478
SIC: 2834 Pharmaceutical Preparations